Delaware Judge Simplifies Amgen’s Legal Battle by Dismissing Indefinite Harbour Medical Patents
In a significant development in the biotech sector, a Delaware federal judge has dismissed two of Harbour Medical’s mouse antibody patents in its infringement case against Amgen’s subsidiary, Immunex. The judge deemed the patents indefinite due to what was described as a term that “everyone agrees” is “nonsensical,” thus simplifying the impending trial for Amgen….